(Q45002710)

8 December 2017

Hepatitis B virus-specific T cell response in chronic hepatitis B patients treated with lamivudine and interferon-alpha (English)

1 reference

8 December 2017

1 reference

1 reference

1 reference

8

1 reference

8 December 2017

3

Debby van Riel

0 references

author name string

Oscar Pontesilli

1

1 reference

8 December 2017

Andeltje B van Nunen

2

1 reference

8 December 2017

Patrizia Carotenuto

4

1 reference

8 December 2017

Hubert G Niesters

5

1 reference

8 December 2017

Fons G Uytdehaag

6

1 reference

8 December 2017

Robert A De Man

7

1 reference

8 December 2017

1 August 2004

1 reference

8 December 2017

1 reference

8 December 2017

24

1 reference

8 December 2017

4

1 reference

8 December 2017

308-315

1 reference

To kill or to cure: options in host defense against viral infection.

8 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0922.X

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0922.X

Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0922.X

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0922.X

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0922.X

Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0922.X

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0922.X

Hepatitis B virus variants in patients receiving lamivudine treatment with breakthrough hepatitis evaluated by serial viral loads and full-length viral sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0922.X

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2004.0922.X

10.1111/J.1478-3231.2004.0922.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference